Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Outcome of Hematopoietic Stem Cell Transplantation in Philadelphia Positive Acute Lymphoblastic Leukemia in the Era of Tyrosine Kinase Inhibitors. A Registry-based Study of the Italian Blood and Marrow Transplantation Society (GITMO)

NCT03821727 is registered in ClinicalTrials.gov with CANDONI ANNA as lead sponsor.

NCT NCT03821727
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03821727 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Outcome of Hematopoietic Stem Cell Transplantation in Philadelphia Positive Acute Lymphoblastic Leukemia in the Era of Tyrosine Kinase Inhibitors. A Registry-based Study of the Italian Blood and Marrow Transplantation Society (GITMO)
Lead sponsor
CANDONI ANNA
Phase
Observational
Overall status
Completed
Start date
October 26, 2016
Completion date
June 30, 2018
Enrollment
441 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

philadelphia positive acute lymphoblastic leukemia, sct